U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587801) titled 'Vaccination Response Modulation With a Targeted Rapamycin Protocol Study' on May 06.
Brief Summary: This study will investigate dialysis recipients' responses to important vaccines.
Research suggests that a medication commonly used by transplant recipients may improve vaccine responses. The investigators will be conducting a clinical trial to see whether a short course of low-dose Sirolimus improves the response to vaccination against respiratory syncytial virus (RSV) and influenza (flu) in patient with kidney disease over 60 years old who receive haemodialysis.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
V...